Apex Clinical Research

Tampa, Florida 33612

0 studies enrolling now · 5 studies all time

What they study most

Crohn Disease, Hepatitis C, Chronic, Nonadherence, Patient

Studies at this site

• A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease — Stopped early
• An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease — Stopped early
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease — Completed
• Digimeds to Optimize Adherence in Patients With Hepatitis C and Increased Risk for Nonadherence — Status unconfirmed